Telbivudine: Clinical Trials

65 trials of Telbivudine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed, 17 unknown, 7 withdrawn, 5 terminated. 32 Phase 4, 16 Phase 3, 6 Not applicable, 6 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 432Completed 14, Unknown 12, Withdrawn 4, Terminated 2
Phase 316Completed 12, Terminated 3, Unknown 1
Not applicable6Withdrawn 3, Completed 2, Unknown 1
Phase 26Completed 5, Unknown 1
Phase 13Completed 2, Unknown 1

Follow this drug Literature Review of Telbivudine trials Research Report on Telbivudine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B
Tenofovir disoproxil, Telbivudine - Chronic Hepatitis B
Phase 4UnknownSeng Gee Lim1462016-04-012019-03-18
Bipolar Proteomic Assay Validation Study
Diagnostic test (LDT) - Major Depressive Disorder, Bipolar I and Bipolar II
CompletedMyriad Genetic Laboratories, Inc.2612016-03-012020-05-14
A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB
HPDC-T cells & Entecavir, Entecavir, HPDC-T cells & IFN-a-2a - Chronic Hepatitis B
Phase 1 / Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University4502015-11-012015-11-26
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Blood sampling for Laboratory Developed Test (LDT) analysis - Down Syndrome, Edwards Syndrome
CompletedProgenity, Inc.7602015-10-012019-08-21
The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation
Telbivudine 600mg, Tenofovir disoproxil fumarate 300mg - Hepatitis B, Chronic
Phase 4CompletedThird Affiliated Hospital, Sun Yat-Sen University1112015-06-012018-08-29
EFFORT Further Extension Study
Telbivudine, Adefovir dipivoxil, off-treatment follow-up - Hepatitis B, Chronic
Phase 4UnknownNanfang Hospital, Southern Medical University1302015-04-012016-07-07
Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection
Telbivudine, Placebo - Chronic Hepatitis B
Phase 3TerminatedNovartis Pharmaceuticals532014-10-312019-09-10
TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction
Tenofovir and telbivudine, Tenofovir - Hepatitis B, Chronic
Phase 1 / Phase 2CompletedFuzhou General Hospital1212014-10-012018-09-24
The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children
Lamivudine, Telbivudine, Tenofovir - the Safety of Anti-viral Drugs Used in Late Pregnancy
UnknownBeijing Ditan Hospital4002014-10-012014-11-26
Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment.
Telbivudine, Lamivudine - HBsAg-positive Renal Allograft Recipients
Phase 4TerminatedNational Taiwan University Hospital192014-07-012016-09-09
Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases
Telbivudine - Chronic Hepatitis B
Not applicableWithdrawnChinese University of Hong Kong2013-12-012016-07-28
Renoprotective Effects of Telbivudine in Chronic Hepatitis B
Telbivudine - Hepatitis B, Chronic, Chronic Kidney Diseases
Phase 4CompletedThe University of Hong Kong312013-08-012018-12-19
Replacement of Lamivudine by Telbivudine to Improve Renal Function
telbivudine - Disorder Related to Transplantation, Virus Diseases
Phase 2 / Phase 3CompletedChang Gung Memorial Hospital1202013-06-012017-02-07
Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial
Telbivudine, Enecavir, Adefovir - HBV-related Liver Cirrhosis
Phase 4UnknownLin Bingliang3002013-02-012013-02-26
To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B
Tenofovir + Telbivudine, Tenofovir - Spontaneous Reactivation of Hepatitis B
Not applicableCompletedInstitute of Liver and Biliary Sciences, India692012-11-012016-03-23
Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis
Telbivudine, Lamivudine, Adefovir ,Enecavir - HBV-related Liver Cirrhosis
Phase 4UnknownShao-quan Zhang1202012-09-012012-09-26
Efficacy of Antiviral Therapy in Pregnancy in Preventing Vertical Transmission of HBV in Mothers With a High Viral Load
telbivudine - Immune Globulin, Prophylaxis, Telbuvidine, Vaccine
UnknownBeijing Ditan Hospital6002012-08-012014-10-01
Antiviral Efficacy of Switching to ETV Plus TDF
Group A (Zeffix, Sebivo, Hepsera), Group B (Baraclude, Viread) - Chronic Hepatitis B
Phase 4UnknownYonsei University1042012-08-012014-01-31
Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B
Telbivudine, Entecavir - Chronic Viral Hepatitis B Without Delta-agent
Phase 3CompletedAsan Medical Center982012-05-012017-01-26
Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir
Telbivudine, Tenofovir, Entecavir - Chronic Hepatitis B
Phase 4UnknownPusan National University Yangsan Hospital1042012-04-012012-05-02

Showing 20 of 65. Sign in to see all of them.

Conditions studied

Hepatitis B, Chronic (41)  ·  Hepatitis B (15)  ·  Fibrosis (2)  ·  Liver Cirrhosis (2)  ·  Aneuploidy (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Carcinoma, Hepatocellular (1)  ·  Chromosome Deletion (1)  ·  Depressive Disorder, Major (1)  ·  DiGeorge Syndrome (1)  ·  Down Syndrome (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  HIV Infections (1)  ·  Heartburn (1)  ·  Hepatitis (1)

Sponsors

Novartis Pharmaceuticals (15)  ·  Novartis (10)  ·  Nanfang Hospital, Southern Medical University (3)  ·  Third Affiliated Hospital, Sun Yat-Sen University (3)  ·  Beijing Ditan Hospital (2)  ·  Chang Gung Memorial Hospital (2)  ·  Institute of Liver and Biliary Sciences, India (2)  ·  The University of Hong Kong (2)  ·  Yonsei University (2)  ·  Asan Medical Center (1)  ·  Beijing YouAn Hospital (1)  ·  Chinese University of Hong Kong (1)  ·  Cz Li (1)  ·  Fudan University (1)  ·  Fuzhou General Hospital (1)

Countries

China (22)  ·  United States (13)  ·  South Korea (12)  ·  Thailand (7)  ·  Germany (6)  ·  Singapore (6)  ·  Taiwan (6)  ·  Canada (5)  ·  France (5)  ·  Hong Kong (5)  ·  India (5)  ·  Israel (5)  ·  Spain (5)  ·  Turkey (Türkiye) (5)  ·  United Kingdom (5)

Top investigators

Hua Zhang, MD (2)  ·  Jinlin Hou, MD (2)  ·  Sang Hoon Ahn, MD, PhD (2)  ·  Wei Yi (2)  ·  Calvin Pan, MD (1)  ·  Chau-ting Yeh, MD,PhD (1)  ·  Chuanwu Zhu, Doctor (1)  ·  Dongliangli Li, Dr. (1)  ·  Dr S. K. Sarin, MD, DM (1)  ·  George Lau, MD (1)  ·  Hyung Joon Yim, M.D (1)  ·  Jia Jidong, Dr. (1)

Results publications

PMID 26329749, PMID 17909201, PMID 18080339, PMID 18094378, PMID 19345439, PMID 20028815, PMID 23234302, PMID 23390496, PMID 23774433, PMID 24431895, PMID 25071343, PMID 25152207, PMID 25187919, PMID 25283499, PMID 28039902, PMID 28103819, PMID 28884132, PMID 29082650, PMID 29193547, PMID 31280390, PMID 32189364, PMID 32460460, PMID 33287722